Coloplast A/S Stock

Coloplast A/S Equity

The The Equity of Coloplast A/S (COLO B.CO) as of Aug 7, 2026 is 16.12 B DKK. In the previous year, The Equity was 17.94 B DKK — a change of -10.14% (lower).

Equity

16.12 BDKK

YoY

-10.14%

Last updated:

In 2026, Coloplast A/S's equity was 16.12 B DKK, a -10.14% increase from the 17.94 B DKK equity in the previous year.

Access this data via the Eulerpool API
Get Free API Key

Coloplast A/S Stock analysis

What does Coloplast A/S do? Coloplast A/S is a Danish company that has been manufacturing products for people with stoma, incontinence, and wound care needs since 1957. The company's headquarters is located in Humlebæk, Denmark, and it employs over 12,000 employees worldwide. Translated: Coloplast A/S is a Danish company that has been manufacturing products for people with stoma, incontinence, and wound care needs since 1957. The company's headquarters is located in Humlebæk, Denmark, and it employs over 12,000 employees worldwide. Coloplast A/S is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Coloplast A/S's Equity

Coloplast A/S's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Coloplast A/S's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Coloplast A/S's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Coloplast A/S's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Coloplast A/S’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Coloplast A/S stock

The Equity of Coloplast A/S is 16.12 B DKK in 2026.

The Equity of Coloplast A/S changed from 17.94 B DKK to 16.12 B DKK, representing a -10.14% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Coloplast A/S since 2006 – with annual values, charts, and detailed analysis.

The Equity's DKK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Coloplast A/S historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Coloplast A/S

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Coloplast A/S